Kotake, Y <br/><br/>
Deprenyl decreases an endogenous parkinsonism-inducing compound, 1-benzyl-1,2,3,4-tetrahydroisoquinoline in mice: in vivo and in vitro studies.  [electronic resource] 

 -  Brain research  Mar 1998 
 - 341-3 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-8993 
<br/><br/><label>Standard No.: </label>10.1016/s0006-8993(97)01560-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Arrhythmia Agents--metabolism<br/>Brain Chemistry--drug effects<br/>Chromatography, Gas<br/>Depression, Chemical<br/>In Vitro Techniques<br/>Isoquinolines--metabolism<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Monoamine Oxidase Inhibitors--pharmacology<br/>Parkinson Disease, Secondary--metabolism<br/>Phenethylamines--metabolism<br/>Selegiline--pharmacology<br/>Tetrahydroisoquinolines